Lyra Therapeutics Inc (LYRA)
0.0995 -0.0055 (-5.24%) 04/28/25 [NASDAQ]
0.0997 x 15,000 0.1150 x 3,000
Realtime by (Cboe BZX)
0.0997 x 15,000 0.1150 x 3,000
Realtime 0.0996 +0.0001 (-) 05:00 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | LYRA | PMCB | KPRX | ||
| Company | Lyra Therapeutics Inc | Pharmacyte Biotech Inc | Kiora Pharmaceuticals Inc. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.1067 | 1.2000 | 3.28 | ||
| High | 0.1067 | 1.2700 | 3.45 | ||
| Low | 0.0968 | 1.2000 | 3.22 | ||
| Last | 0.0995 | 1.2100 | 3.30 | ||
| Change | -0.0055 | -0.0100 | +0.10 | ||
| % Change | -5.24% | -0.82% | +3.12% | ||
| Volume | 1,479,000 | 11,200 | 60,700 | ||
| 20-Day Average Volume | 1,792,450 | 14,520 | 12,230 | ||
| Previous Close | 0.1050 | 1.2200 | 3.20 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1019 | 1.2075 | 2.86 | ||
| 20-Day Raw Stochastic | 27.34% | 41.86% | 84.04% | ||
| 20-Day Relative Strength | 38.03% | 42.27% | 58.78% | ||
| Weighted Alpha | -75.33 | -46.04 | -16.08 | ||
| Today's Opinion | 100% Sell | 88% Sell | 56% Sell | ||
| Previous Opinion | 88% Sell | 88% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Sell | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.97% since 04/21/25 | +7.08% since 04/21/25 | +14.98% since 04/21/25 | ||
| Low | 0.0871 on 04/22/25 | 1.1100 on 04/22/25 | 2.94 on 04/22/25 | ||
| High | 0.1067 on 04/28/25 | 1.3200 on 04/24/25 | 3.45 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -28.37% since 03/28/25 | -8.33% since 03/28/25 | +7.14% since 03/28/25 | ||
| Low | 0.0820 on 04/09/25 | 1.0300 on 04/17/25 | 2.51 on 04/07/25 | ||
| High | 0.1460 on 03/31/25 | 1.4600 on 03/31/25 | 3.45 on 04/28/25 | ||
| 3-Month | |||||
| %Chg | -45.60% since 01/28/25 | -24.87% since 01/28/25 | -10.57% since 01/28/25 | ||
| Low | 0.0820 on 04/09/25 | 1.0300 on 04/17/25 | 2.51 on 04/07/25 | ||
| High | 0.2218 on 02/24/25 | 1.9000 on 02/21/25 | 4.14 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | -60.72% since 10/28/24 | -32.40% since 10/28/24 | -18.32% since 10/28/24 | ||
| Low | 0.0820 on 04/09/25 | 1.0300 on 04/17/25 | 2.51 on 04/07/25 | ||
| High | 0.2970 on 10/30/24 | 2.4229 on 10/30/24 | 4.14 on 01/31/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,945 | 8,511 | 7,879 | ||
| Shares Outstanding, K | 65,881 | 6,864 | 3,001 | ||
| Annual Sales | 1,530,000 | 0 | 16,020,000 | ||
| Annual Net Income | -93,440,000 | 330,000 | 3,590,000 | ||
| Last Quarter Sales | 210,000 | 0 | 0 | ||
| Last Quarter Net Income | -10,980,000 | -3,050,000 | -3,410,000 | ||
| 60-Month Beta | 0.04 | -0.53 | -0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 03/13/25 | -0.10 on 03/17/25 | -1.04 on 03/25/25 | ||
| Latest Earnings Date | 04/29/25 | 03/17/25 | 05/09/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 3.08 | ||